Fig. 3
From: Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3
Knockdown of circSMAD2 inhibited the expression of SMAD2 in GBC cells. (A) The enrichment of circSMAD2 was tested by RIP. (B) The correlation between circSMAD2 and eIF4A3 was explored by RNA pull-down. (C) The level of SMAD2 in GBC cells was detected by RT-qPCR. (D, E) The protein level of SMAD2 in GBC cells was investigated by western blot. The relative level was quantified by normalizing to β-actin. **P < 0.01 compared to control